[CYCC] YoY Quarter Result on 31-Mar-2011 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
16-May-2011
Financial Year
2011
Quarter
31-Mar-2011 [#Q1]
Profit Trend
QoQ- -44.64%
YoY- 10.23%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Revenue 396 212 161 192 271 228 177 14.35%
PBT -5,446 -3,356 -3,123 -4,779 -5,244 -5,421 -6,927 -3.92%
Tax -569 -258 -168 -191 -133 -358 -675 -2.80%
NP -4,869 -3,082 -2,955 -4,588 -5,111 -5,063 -6,252 -4.07%
Tax Rate - - - - - - - -
Total Cost 5,265 3,294 3,116 4,780 5,382 5,291 6,429 -3.27%
Ratio Analysis
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
NP Margin -1,229.55 -1,453.77 -1,835.40 -2,389.58 -1,885.98 -2,220.61 -3,532.20 -16.12%
Per Share
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
EPS -59.83 -75.55 -90.66 -165.51 -270.70 -416.30 -514.06 -30.11%
EPS Diluted -59.83 -75.55 -90.66 -165.51 -270.70 -416.30 -514.06 -30.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.